Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 11.10.2024Janssen Biologics B.V. (JAN-NL)02578Remicade 100 mg prášok na prípravu infúzneho koncentrátu (plc ifc 1x100 mg (liek.inj.skl.))11.10.2024O
 11.10.2024Wörwag Pharma GmbH & Co. KG (WGP-1)10890Thiogamma Turbo-Set (sol inf 10x50 ml/600 mg (fľ.inf.))11.10.2024R
 11.10.2024Wörwag Pharma GmbH & Co. KG (WGP-1)90159Carvedigamma 12,5 mg filmom obalené tablety (tbl flm 30x12,5 mg (blis.PVC/Al))9.10.2024O
 11.10.2024G.L. Pharma GmbH (GLH-2)96306Neurotop retard 600 mg (tbl plg 50x600 mg (blis.PVC/PVDC/Al))9.10.2024O
 11.10.2024CSL Behring GmbH (CSL)50934Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x50 ml (liek.inj.skl.))10.10.2024O
 11.10.2024CSL Behring GmbH (CSL)50935Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml (liek.inj.skl.))10.10.2024O
 11.10.2024CSL Behring GmbH (CSL)50936Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml (liek.inj.skl.))10.10.2024O
 11.10.2024CSL Behring GmbH (CSL)80027Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x25 ml (liek.inj.skl.))10.10.2024O
 10.10.2024B.Braun Melsungen AG (BME)1344CNutriflex Omega special 56/144 (emu inf 5x1250 ml (vak infúzny viackomorový))10.10.2024R
 10.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2422AContiroxil 40 mg tablety s predĺženým uvoľňovaním (tbl plg 56x40 mg (blisPVC/PE/PVDC))15.10.2024O
 10.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28856Amoksiklav 2x1000 mg (tbl flm 14x1000 mg (blis.Al/Al))10.10.2024O
 10.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)58702TAMOXIFEN Sandoz 20 mg (tbl 100x20 mg (liek.PP))15.10.2024O
 10.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))10.10.2024O
 10.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))10.10.2024O
 10.10.2024Olikla s.r.o. (OLK)5448DMicafungin Olikla 100 mg prášok na infúzny koncentrát (plc ifc 1x100 mg (liek.inj.skl.))1.11.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)